NCT03114345

Brief Summary

Paraplegic patients have defective wound healing for sore below the level of spinal lesion. Defect of vascularization of the healing zone certainly participate to this effect. Therefore, this study want to measure, in a clinical settings, the interface pressure (e.g. the pressure between the patient body and the surface he/she is lying on) to assess the correlation between mechanical stress in term of pressure applied over time and tissue oxygenation which represent micro-vascular function. The aim of this clinical trial is to correlate the variations of pressure intensities and changes in micro-vascularization. The measure are recorded when paraplegic patient came into the hospital for pressure ulcer related surgery. The patient is laying on his/her mattress on top of a flexible pressure mapping device. The micro-vascularization parameters are measured at the area displaying the peak pressure a few minutes after the beginning of the pressure interface recording and one hour later at the same area. The data generated during this monocentric study will help to achieve a better understanding of the relation between pressure and micro-vascularization. In the mid term, it will provide a better and more patient adapted pressure ulcer prevention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 14, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

November 22, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 22, 2019

Completed
Last Updated

December 9, 2021

Status Verified

December 1, 2021

Enrollment Period

2 years

First QC Date

March 30, 2017

Last Update Submit

December 8, 2021

Conditions

Keywords

Pressure ulcerInterface pressurePressure mapping deviceMonitoringMicrovascularization

Outcome Measures

Primary Outcomes (2)

  • Measure of the pressure intensity in one area

    Pressure intensity is recorded using a mapping pressure device (XSensor), set up on the patient hospital bed. Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.

    Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.

  • Measure of the hemoglobin quantity in the same area

    Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.

    Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.

Secondary Outcomes (1)

  • Measure of other micro-vascularization related parameters (such as the oxygen saturation and the blood flow) recorded at the same area.

    Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.

Study Arms (1)

Single arm

OTHER

Measurement of interface pressure and Measurement of micro-vascularization related parameters

Other: Measurement of interface pressureOther: Measurement of micro-vascularization related parameters

Interventions

A capacitive pressure mapping device (XSensor) is set up on the patient air mattress bed. It records the interface pressure on the whole patient body with one frame every second during one hour. Then the file is saved and the pressure mapping device is removed from the patient hospital bedroom.

Single arm

A medical device called O2C, measuring micro-vascularization related parameters (oxygen saturation, hemoglobin quantity and blood flow) is used. The probe (= an optic fibre) is set up lightly on the patient skin or on a transparent adhesive for 1 minute. The median value of the local micro-vascularization parameters are saved on the O2C interface. The location of the measurement is chosen using the pressure mapping device to locate peak pressure area. Then the O2C is removed from the patient hospital bedroom.

Single arm

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Educated consent signed,
  • Older than 18,
  • Paraplegia for at least 6 months,
  • Surgery planned for pressure ulcer resection,

You may not qualify if:

  • Dementia,
  • Stade IV arteritis non-revascularisable,
  • Patient with no health insurance,
  • Pregnant women or breast-feeding, patient unable to give his or her educated consent, ward of the state (art. L.1121-6, L.1121-7, L.1211-8, L.1211-9),
  • Patient taking part in another study which could impact the local micro-vascularization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Regional Hospital Lapeyronie

Montpellier, Languedoc-Roussillon, 34295, France

Location

MeSH Terms

Conditions

Pressure UlcerSpinal Cord InjuriesParaplegia

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue DiseasesSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Stefan Matecki, M.D.

    CHU de Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2017

First Posted

April 14, 2017

Study Start

November 22, 2017

Primary Completion

November 22, 2019

Study Completion

November 22, 2019

Last Updated

December 9, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations